Lilly Dermatology Division?

Taltz is doing horribly. Probably one of the absolute worst launches of any biologics used for psoriasis. The definition of a "me too" following the successful launch of Cosentyx. Higher rates of immunogenicity compared to Cosentyx. Higher rates of injection site reaction. Same efficacy. Doesn't add anything different or more valuable to dermatologists or to patients. It was literally a race of who will launch first: Novartis or Lilly. And Novartis won that race. I know dermatologists who literally told me they throw anything they get about Taltz in the main straight in the garbage.
 






Taltz is doing horribly. Probably one of the absolute worst launches of any biologics used for psoriasis. The definition of a "me too" following the successful launch of Cosentyx. Higher rates of immunogenicity compared to Cosentyx. Higher rates of injection site reaction. Same efficacy. Doesn't add anything different or more valuable to dermatologists or to patients. It was literally a race of who will launch first: Novartis or Lilly. And Novartis won that race. I know dermatologists who literally told me they throw anything they get about Taltz in the main straight in the garbage.
 










































Taltz is doing horribly. Probably one of the absolute worst launches of any biologics used for psoriasis. The definition of a "me too" following the successful launch of Cosentyx. Higher rates of immunogenicity compared to Cosentyx. Higher rates of injection site reaction. Same efficacy. Doesn't add anything different or more valuable to dermatologists or to patients. It was literally a race of who will launch first: Novartis or Lilly. And Novartis won that race. I know dermatologists who literally told me they throw anything they get about Taltz in the main straight in the garbage.
 






Taltz is doing horribly. Probably one of the absolute worst launches of any biologics used for psoriasis. The definition of a "me too" following the successful launch of Cosentyx. Higher rates of immunogenicity compared to Cosentyx. Higher rates of injection site reaction. Same efficacy. Doesn't add anything different or more valuable to dermatologists or to patients. It was literally a race of who will launch first: Novartis or Lilly. And Novartis won that race. I know dermatologists who literally told me they throw anything they get about Taltz in the main straight in the garbage.
It's true. Docs are trying it but starting to get complaints about the injection site reactions. They don't need that headache.
 
























marianne matzke is a horrible manager.

She can seem very harsh to those who are incompetent and unable to excel in challenging situations. To the top performers, she's a fantastic coach and mentor. I give her my highest marks for leadership and going above and beyond in breaking down barriers to success.
 
























She can seem very harsh to those who are incompetent and unable to excel in challenging situations. To the top performers, she's a fantastic coach and mentor. I give her my highest marks for leadership and going above and beyond in breaking down barriers to success.

Thanks MM! Not surprised to see you adding your comments to the board.